Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

Novo Nordisk

251.85 DKK

+2.32 %

1,012 following

NOVO B

NASDAQ Copenhagen

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Novo Nordisk

P/E

Median 2019-2025

EV/S

Median 2019-2024

EV/EBIT

Median 2019-2024

Dividend yield

Median 2019-2025

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (DKK)193.33213.33367.50469.00698.10624.20325.25
Shares4,747.24,669.04,594.24,508.04,510.04,446.24,444.0
Market cap917,757.9996,020.81,688,378.82,114,252.03,148,431.02,775,318.01,445,411.0
Enterprise value908,099.9995,018.81,698,818.82,127,383.03,161,045.02,862,450.0-
EV/S7.47.812.112.013.69.9-
EV/EBITDA15.616.626.325.928.219.4-
EV/EBIT17.318.429.028.430.822.3-
P/E23.623.635.438.337.427.514.1
P/B15.9415.7323.8725.3229.5519.347.45
P/S7.57.812.011.913.69.64.7
Dividend yield2.2 %2.1 %1.4 %1.3 %1.4 %1.8 %3.6 %
Equity ratio45.8 %43.7 %36.4 %34.6 %33.9 %30.8 %35.7 %
Gearing ratio10.1 %18.6 %39.5 %30.9 %25.3 %71.6 %67.5 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.